Previous 10 | Next 10 |
home / stock / szls:cc / szls:cc news
Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnost...
Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational results after the market closes on Friday March 31, 2023. StageZero's Chairman and CEO, Ja...
Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational results after the market closes on Thursday March 30, 2023. StageZero's Chairman and CEO, ...
Launch of New Protocol will now make the connection between patients' metabolic health and cancer outcomes using advanced biomarker testing and interactive digital health platform to actively track patient progress. Toronto, Ontario--(Newsfile Corp. - February 15, 2023) - StageZero Life Science...
Toronto, Ontario--(Newsfile Corp. - February 2, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) (" StageZero " or the " Company "), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through le...
TORONTO, ON / ACCESSWIRE / January 12, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge m...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESSWIRE / November 21, 2022 / StageZero Life Sciences Ltd. ("StageZero" or the "Company") (TSX:SZLS) today announced that it has entered into a capital commitment agreement (the "Ag...
TORONTO, ON / ACCESSWIRE / November 15 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS)(OTCQB:SZLSF), a vertically-integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular...
TORONTO, ON / ACCESSWIRE / November 11, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its third quarter operational and financial results before the markets open on Tuesday, November 15, 2022. StageZero's Chairman and CEO, James...
TORONTO, ON and RICHMOND, VA / ACCESSWIRE / August 18, 2022 / StageZero Life Sciences, Ltd (TSX:SZLS) (" StageZero " or the " Company "), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-ed...
News, Short Squeeze, Breakout and More Instantly...
Stagezero Life Sciences Ltd. Company Name:
SZLS:CC Stock Symbol:
TSXC Market:
TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) (" StageZero " or the " Company "), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aris...
TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for screening for multiple, key cancers from a single sample of blood - Aristotle, and an oncologist-...
Canadian Investment Regulatory Organization Trading Halt - SZLS Canada NewsWire TORONTO , April 9, 2024 /CNW/ - The following issues have been halted by CIRO: Company: StageZero Life Sciences Ltd. TSX Symbol: SZLS All Issues: Yes Reason: Cease Trade O...